MYRIAD GENETICS, INC. Gain (Loss) on Termination of Lease
MYRIAD GENETICS, INC. (MYGN) reported Gain (Loss) on Termination of Lease of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-02-24
- MYRIAD GENETICS, INC. gain (loss) on termination of lease for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- MYRIAD GENETICS, INC. gain (loss) on termination of lease for the quarter ending 2024-03-31 was $3.10M.
- MYRIAD GENETICS, INC. gain (loss) on termination of lease for the quarter ending 2023-03-31 was $0.00.
- MYRIAD GENETICS, INC. gain (loss) on termination of lease for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- MYRIAD GENETICS, INC. gain (loss) on termination of lease for fiscal 2024 was $3.10M.
- MYRIAD GENETICS, INC. gain (loss) on termination of lease for fiscal 2023 was -$7.70M.
- MYRIAD GENETICS, INC. gain (loss) on termination of lease for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | $3.10M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $3.10M 10-Q · filed 2025-11-04 | |||
| 2024-06-30 | $3.10M 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $3.10M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | -$7.70M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |